Patents by Inventor D. Craig Allred

D. Craig Allred has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions in breast cancer diagnosis and therapeutics
    Patent number: 7429650
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: September 30, 2008
    Assignee: Baylor College of Medicine
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Methods and compositions in breast cancer diagnosis and therapeutics
    Patent number: 7419785
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: July 21, 2004
    Date of Patent: September 2, 2008
    Assignee: Baylor College of Medicine
    Inventors: Suzanne Fuqua, D. Craig Allred, Peter O'Connell, Torsten A. Hopp
  • Methods and compositions in breast cancer diagnosis and therapeutics
    Publication number: 20040265895
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Application
    Filed: July 21, 2004
    Publication date: December 30, 2004
    Inventors: Suzanne Fuqua, D. Craig Allred, Peter O'Connell, Torsten A. Hopp
  • Methods and compositions in breast cancer diagnosis and therapeutics
    Patent number: 6821732
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: November 23, 2004
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Methods and compositions in breast cancer diagnosis and therapeutics
    Publication number: 20030186313
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Application
    Filed: May 13, 2003
    Publication date: October 2, 2003
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Methods and compositions in breast cancer diagnosis and therapeutics
    Publication number: 20030027778
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Application
    Filed: January 18, 2002
    Publication date: February 6, 2003
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp